Abstract
Breast cancer (BC) continues to be a public health burden and has higher incidence (BCI) in certain disease populations. Currently, BCI and Atopic Dermatitis (AD) studies produce mixed findings. Administrative data may assist in detangling this relationship. However, use of validated algorithms (VAs) for administrative data targeting the general population may not be reliable in certain disease indications. Therefore, we explored BCI VA reliability in both the general population and an AD population.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
